Clinico-etiological profile of COVID- 19 positive paediatrics patients in a tertiary care hospital: A retrospective study

V. Y Kshirsagar; Vijayalaxmi Budihal

doi:10.53730/ijhs.v6nS3.5712

Authors

V. Y Kshirsagar Professor and Head Department of Paediatrics, Krishna Institute of Medical Sciences Deemed to be University, Karad, 415510
Vijayalaxmi Budihal Paediatric Resident, Department of Paediatrics, Krishna Institute of Medical Sciences Deemed to be University, Karad, 415510

Keywords:

COVID-19, SARS-CoV-2, risk factors, severity, clinico-etiological profile, asymptomatic patients

Abstract

With the sudden outbreak of corona virus pandemic in 2019, there is a paucity of data on the clinical and epidemiological profile of COVID positive paediatric patients. Objective of the study was a retrospective analysis of clinico-etiological profile of COVID-19 paediatric patients admitted to a tertiary care centre Karad. A retrospective cross-sectional study was conducted in the Paediatric Department of tertiary care hospital Krishna Institute of medical sciences deemed to be university, Karad, from 22 March 2020 till 30 November 2020. A total of 154 children were enrolled. Among neonates, all were born to COVID-19 positive mothers and were asymptomatic and SARI in children less than 1 year (excluding neonates) (33%) and in the 1-5 years age group (15.8%). In children more than 5 years, acute febrile illnesses were the main admitting diagnosis (27.5%). Asymptomatic children (33.7%) dominated the COVID19 positive group. The most common symptom included fever (35.7%) with no reported mortality. Atypical symptoms (64.3%) were more common than respiratory symptoms. The majority of children had mild COVID-19 symptoms (67%). The unusual presentation of COVID-19 was in the form of diarrhoea (9.7%) in the symptomatic group.

Downloads

Download data is not yet available.

References

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China JAMA. 2020; 323:1061–9.

Gupta N, Praharaj I, Bhatnagar T, et al. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020; 151:236–40.

Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 case surveillance – United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:759–65.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID–19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020; 323:1239–42.

Han MS, Choi EH, Chang SH, et al. Clinical Characteristics and Viral RNA Detection in Children with coronavirus disease 2019 in the Republic of Korea. JAMA Pediatr. 2021; 175:73–80.

Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020; 145:e20200702.

Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper–infammatory syndrome in a child with covid–19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020; 57:681–

Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profle of pediatric infammatory multisystem syndrome – temporally associated with SARS–CoV–2 (PIMS–TS) in Indian children. Indian Pediatr. 2020; 57:1010–4.

Clinical management of severe acute respiratory infection when COVID– 19 is suspected. Available at: https://www.who.int/publications–detail/ clinical–management of–severe–acuterespiratory–infection–when– novel–coronavirus–(ncov)–infection–issuspected. Accessed on 31 Oct 2020.

Revised Guidelines on Clinical Management of COVID – 19 Government of India. Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division).

Weiss SL, Peters MJ, Alhazzani W, et al. Surviving Sepsis campaign international guidelines for the management of septic shock and sepsis–associated organ dysfunction in children. PediatrCrit Care Med. 2020; 21:e52–106.

Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi–system infammatory syndrome in children (MIS–C) following SARS–CoV–2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020; 7:69.

Information for healthcare providers about multisystem infammatory syndrome in children (MIS–C). In: Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/mis–c/ hcp/. Accessed on 12 Aug 2020.

Choi S-H, Kim HW, Kang J–M, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease, in children. Clin Exp Pediatr. 2019; 2020(63):125–32.

Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID–19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020; 174:868–73.

Liguoro I, Pilotto C, Bonanni M, et al. SARS–COV–2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020; 179:1029–46.

Banerjee S, Guha A, Das A, Nandi M, Mondal R. A Preliminary Report of COVID 19 in Children in India. Indian Pediatr. 2020; 57:963–4.

Lu X, Zhang L, Du H, et al. SARS–CoV–2 infection in children. N Engl J Med. 2020; 382:1663–5.

Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS–CoV–2 infection in children: a systematic review and meta–analysis. Indian Pediatr. 2020; 57:820–6.

Hoang A, Chorath K, Moreira A, et al. COVID–19 in 7780 pediatric patients: a systematic review. Eclinical Medicine. 2020; 24:100433.

Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID–19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020; 20:689–96.

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507–13.

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID–19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020; 34:101623.

24.Liang Su, Xiang Ma, Huafeng Yu, Zhaohua Zhang, PengfeiBian, Yuling Han,Jing Sun, et al., The different clinical characteristics of corona virus disease cases between children and their families in China–the character of children with COVID- 19, Emerging Microbes & Infections 9 (1) (2020) 707–713, https://doi.org/10. 1080/22221751.2020.1744483.

25.M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, T.S. Schiergens, G. Herrler, N.H. Wu, A. Nitsche, M.A. Müller, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell (2020), https://doi.org/10.1016/j.cell.2020.02.052.

26.Jiehao Cai, Jing Xu, Daojiong Lin, Lei Xu, Zhenghai Qu, Yuehua Zhang, Hua Zhang, et al., A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features, Clinical Infectious Diseases (2020), https://doi.org/10. 1093/cid/ciaa198.